September 18 2024 - FDA scraps adcomm for Applied's rare disease drug ahead of November decision

FDA scraps adcomm for Applied's rare disease drug ahead of November decision
Ascendis trial data piles pressure on BioMarin
Agency warns J&J over 340B rebate plan
GSK touts co-administration data for RSV, shingles vaccines
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

*please scroll down for all the latest news*